People · Operator
Named in public records as an officer, director or promoter · active 2012–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tissue Regeneration Systems Inc | — | Biotechnology | Series A | $13.2M | $148.0M | 2012 |
James R. Adox at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James R. Adox on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Colleen James Spencer | 1 | 1 |
| Frank R. LaMarca | 1 | 1 |
| Scott J. Hollister | 1 | 1 |
| William James Fitzsimmons | 1 | 1 |
| Henry R. Brown | 1 | 1 |
| Stephen James Feinberg | 1 | 1 |
| Thomas E. Porter | 1 | 1 |
| William L. Murphy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.